Takeda Sues Torrent Over Diabetes Drug Patents

Law360, New York (July 6, 2009, 12:00 AM EDT) -- Takeda Pharmaceutical Co. Ltd. has taken aim at generics maker Torrent Pharmaceuticals Ltd., accusing the company of infringing the method claims of seven patents related to the diabetes treatment Actos.

Takeda filed suit Thursday in the U.S. District Court for the Southern District of New York, claiming an abbreviated new drug application Torrent filed with the U.S. Food and Drug Administration infringed its patents and seeking to bar Torrent's proposed generic pill until 2016, when the patents-in-suit expire.

According to the complaint, the patents cover various...
To view the full article, register now.